Compare Stocks

Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities.

CompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's Volume
AtriCure, Inc. stock logo
ATRC
AtriCure
$55.39
+2.4%
$57.65
$25.36
▼
$66.02
$2.82B1.23862,795 shs317,706 shs
Integra LifeSciences Holdings Corporation stock logo
IART
Integra LifeSciences
$13.26
-2.2%
$14.13
$8.70
▼
$20.49
$1.03B1.28933,058 shs573,120 shs
iRhythm Technologies stock logo
IRTC
iRhythm Technologies
$94.84
+0.6%
$109.62
$82.85
▼
$192.47
$3.19B1.39635,503 shs598,492 shs
Pulse Biosciences, Inc stock logo
PLSE
Pulse Biosciences
$45.46
+2.4%
$51.30
$12.70
▼
$58.94
$3.34B1.65392,801 shs296,965 shs
Forget Nvidia, Meta, and Google. Here's The New Magnificent Seven. Cover

Discover the next wave of investment opportunities with our report, 7 Stocks That Will Be Magnificent in 2026. Explore companies poised to replicate the growth, innovation, and value creation of the tech giants dominating today's markets.

Get This Free Report

Compare Price Performance

Company1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year Performance
AtriCure, Inc. stock logo
ATRC
AtriCure
-2.42%-3.34%-6.17%+10.47%+58.31%
Integra LifeSciences Holdings Corporation stock logo
IART
Integra LifeSciences
-2.24%-5.57%+1.65%-19.06%+21.52%
iRhythm Technologies stock logo
IRTC
iRhythm Technologies
-0.66%+0.73%-17.22%-26.67%-43.63%
Pulse Biosciences, Inc stock logo
PLSE
Pulse Biosciences
-3.10%-15.00%-12.65%-11.92%+241.35%
CompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's Volume
AtriCure, Inc. stock logo
ATRC
AtriCure
$55.39
+2.4%
$57.65
$25.36
▼
$66.02
$2.82B1.23862,795 shs317,706 shs
Integra LifeSciences Holdings Corporation stock logo
IART
Integra LifeSciences
$13.26
-2.2%
$14.13
$8.70
▼
$20.49
$1.03B1.28933,058 shs573,120 shs
iRhythm Technologies stock logo
IRTC
iRhythm Technologies
$94.84
+0.6%
$109.62
$82.85
▼
$192.47
$3.19B1.39635,503 shs598,492 shs
Pulse Biosciences, Inc stock logo
PLSE
Pulse Biosciences
$45.46
+2.4%
$51.30
$12.70
▼
$58.94
$3.34B1.65392,801 shs296,965 shs
Forget Nvidia, Meta, and Google. Here's The New Magnificent Seven. Cover

Discover the next wave of investment opportunities with our report, 7 Stocks That Will Be Magnificent in 2026. Explore companies poised to replicate the growth, innovation, and value creation of the tech giants dominating today's markets.

Get This Free Report

Compare Price Performance

Company1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year Performance
AtriCure, Inc. stock logo
ATRC
AtriCure
-2.42%-3.34%-6.17%+10.47%+58.31%
Integra LifeSciences Holdings Corporation stock logo
IART
Integra LifeSciences
-2.24%-5.57%+1.65%-19.06%+21.52%
iRhythm Technologies stock logo
IRTC
iRhythm Technologies
-0.66%+0.73%-17.22%-26.67%-43.63%
Pulse Biosciences, Inc stock logo
PLSE
Pulse Biosciences
-3.10%-15.00%-12.65%-11.92%+241.35%
CompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current Price
AtriCure, Inc. stock logo
ATRC
AtriCure
2.58
Moderate Buy$62.3012.48% Upside
Integra LifeSciences Holdings Corporation stock logo
IART
Integra LifeSciences
1.90
Reduce$16.1321.65% Upside
iRhythm Technologies stock logo
IRTC
iRhythm Technologies
2.82
Moderate Buy$164.0773.00% Upside
Pulse Biosciences, Inc stock logo
PLSE
Pulse Biosciences
2.86
Moderate Buy$66.6046.49% Upside

Current Analyst Ratings Breakdown

Latest IART, IRTC, PLSE, and ATRC Analyst Ratings

DateCompanyBrokerageActionRatingPrice TargetDetails
11/17/2026
Pulse Biosciences, Inc stock logo
PLSE
Pulse Biosciences
Reiterated RatingBuy$64.00
11/12/2026
iRhythm Technologies stock logo
IRTC
iRhythm Technologies
DowngradeSell (D-) ➝ Sell (E+)
11/12/2026
AtriCure, Inc. stock logo
ATRC
AtriCure
Set Price Target$70.00
11/11/2026
iRhythm Technologies stock logo
IRTC
iRhythm Technologies
Lower Price TargetOverweight$160.00 ➝ $120.00
11/9/2026
iRhythm Technologies stock logo
IRTC
iRhythm Technologies
Lower Price TargetBuy$168.00 ➝ $140.00
11/6/2026
Pulse Biosciences, Inc stock logo
PLSE
Pulse Biosciences
Set Price Target$65.00
11/6/2026
iRhythm Technologies stock logo
IRTC
iRhythm Technologies
Boost Price TargetBuy$196.00 ➝ $206.00
11/6/2026
iRhythm Technologies stock logo
IRTC
iRhythm Technologies
Lower Price TargetOverweight$175.00 ➝ $145.00
11/6/2026
iRhythm Technologies stock logo
IRTC
iRhythm Technologies
Lower Price TargetOverweight$150.00 ➝ $135.00
11/6/2026
iRhythm Technologies stock logo
IRTC
iRhythm Technologies
Lower Price TargetOverweight$160.00 ➝ $150.00
11/6/2026
iRhythm Technologies stock logo
IRTC
iRhythm Technologies
Lower Price TargetBuy$185.00 ➝ $170.00
(Data available from 11/20/2023 forward. View 10+ years of historical ratings with our analyst ratings screener.)
CompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/Book
AtriCure, Inc. stock logo
ATRC
AtriCure
$534.53M5.28$0.31 per share177.16$10.47 per share5.29
Integra LifeSciences Holdings Corporation stock logo
IART
Integra LifeSciences
$1.64B0.63$4.04 per share3.28$13.71 per share0.97
iRhythm Technologies stock logo
IRTC
iRhythm Technologies
$747.14M4.27N/AN/A$5.27 per share18.00
Pulse Biosciences, Inc stock logo
PLSE
Pulse Biosciences
$1.49M2,238.12N/AN/A$2.50 per share18.19
CompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings Date
AtriCure, Inc. stock logo
ATRC
AtriCure
-$11.45M$0.30184.63110.77N/A2.52%4.01%3.03%N/A
Integra LifeSciences Holdings Corporation stock logo
IART
Integra LifeSciences
-$516.47M$0.1777.975.590.990.79%18.63%5.49%N/A
iRhythm Technologies stock logo
IRTC
iRhythm Technologies
-$44.55M-$1.17N/A57.13N/A-4.52%26.88%4.32%N/A
Pulse Biosciences, Inc stock logo
PLSE
Pulse Biosciences
-$72.78M-$1.21N/AN/AN/A-5,603.88%-77.88%-67.89%N/A

Latest IART, IRTC, PLSE, and ATRC Earnings

DateQuarterCompanyConsensus EstimateReported EPSBeat/MissGap EPSRevenue EstimateActual RevenueDetails
11/5/2026Q3 2026
iRhythm Technologies stock logo
IRTC
iRhythm Technologies
$0.0155$0.82+$0.8045-$0.90$222.23 million$221.59 million
11/5/2026Q3 2026
Pulse Biosciences, Inc stock logo
PLSE
Pulse Biosciences
-$0.3095-$0.32-$0.0105-$0.2430$0.52 million$0.40 million
11/3/2026Q3 2026
AtriCure, Inc. stock logo
ATRC
AtriCure
-$0.0552$0.17+$0.2252$0.08$151.05 million$154.45 million
10/21/2026Q3 2026
Integra LifeSciences Holdings Corporation stock logo
IART
Integra LifeSciences
$0.5570$0.59+$0.0330$0.19$413.16 million$411.18 million
CompanyAnnual PayoutDividend Yield5-Year Annualized Dividend GrowthPayout RatioYears of Consecutive Growth
AtriCure, Inc. stock logo
ATRC
AtriCure
N/AN/AN/AN/AN/A
Integra LifeSciences Holdings Corporation stock logo
IART
Integra LifeSciences
N/AN/AN/AN/AN/A
iRhythm Technologies stock logo
IRTC
iRhythm Technologies
N/AN/AN/AN/AN/A
Pulse Biosciences, Inc stock logo
PLSE
Pulse Biosciences
N/AN/AN/AN/AN/A
CompanyDebt-to-Equity RatioCurrent RatioQuick Ratio
AtriCure, Inc. stock logo
ATRC
AtriCure
0.17
4.33
3.29
Integra LifeSciences Holdings Corporation stock logo
IART
Integra LifeSciences
1.67
3.62
2.21
iRhythm Technologies stock logo
IRTC
iRhythm Technologies
3.68
3.57
3.45
Pulse Biosciences, Inc stock logo
PLSE
Pulse Biosciences
N/A
14.35
14.33

Institutional Ownership

CompanyInstitutional Ownership
AtriCure, Inc. stock logo
ATRC
AtriCure
99.11%
Integra LifeSciences Holdings Corporation stock logo
IART
Integra LifeSciences
84.78%
iRhythm Technologies stock logo
IRTC
iRhythm Technologies
N/A
Pulse Biosciences, Inc stock logo
PLSE
Pulse Biosciences
76.95%

Insider Ownership

CompanyInsider Ownership
AtriCure, Inc. stock logo
ATRC
AtriCure
4.00%
Integra LifeSciences Holdings Corporation stock logo
IART
Integra LifeSciences
3.84%
iRhythm Technologies stock logo
IRTC
iRhythm Technologies
0.98%
Pulse Biosciences, Inc stock logo
PLSE
Pulse Biosciences
74.00%
CompanyEmployeesShares OutstandingFree FloatOptionable
AtriCure, Inc. stock logo
ATRC
AtriCure
1,35050.92 million48.89 millionOptionable
Integra LifeSciences Holdings Corporation stock logo
IART
Integra LifeSciences
4,42777.80 million74.81 millionOptionable
iRhythm Technologies stock logo
IRTC
iRhythm Technologies
2,40033.62 million33.29 millionOptionable
Pulse Biosciences, Inc stock logo
PLSE
Pulse Biosciences
11673.55 million19.12 millionOptionable

Recent News About These Companies

Pulse Biosciences Earnings Call Signals Clinical Momentum
Pulse Biosciences (NASDAQ:PLSE) Cut to "Sell" at Wall Street Zen
Pulse Biosciences (NASDAQ:PLSE) Price Target Raised to $74.00

New MarketBeat Followers Over Time

Media Sentiment Over Time

AtriCure stock logo

AtriCure NASDAQ:ATRC

$55.39 +1.28 (+2.36%)
Closing price 03:59 PM Eastern
Extended Trading
$55.42 +0.04 (+0.07%)
As of 04:04 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.

AtriCure, Inc. develops, manufactures, and sells devices for surgical ablation of cardiac tissue, exclusion of the left atrial appendage, and temporarily blocking pain by ablating peripheral nerves to medical centers in the United States, Europe, the Asia-Pacific, and internationally. The company offers Isolator Synergy Clamps, single-use disposable radio frequency products; multifunctional pens and linear ablation devices, such as the MAX Pen device that enables surgeons to evaluate cardiac arrhythmias, perform temporary cardiac pacing, sensing, and stimulation, and ablate cardiac tissue with the same device; and the Coolrail device, which enables users to make longer linear lines of ablation. It also provides cryoICE Cryoablation System that enables the user to make linear ablations of varied lengths; EPi-Sense Systems, a single-use disposable device used for the treatment of symptomatic, drug-refractory, and long-standing persistent atrial fibrillation; cryoSPHERE probe, which provides temporary pain relief by applying cryothermic energy to targeted intercoastal peripheral nerves in the ribcage; AtriClip System, an implantable device coupled to a single-use disposable applier; and LARIAT System, a suture-based solution for soft-tissue closure. In addition, the company sells Lumitip dissectors to separate tissues to provide access to key anatomical structures that are targeted for ablation; Glidepath guides for placement of clamps; Subtle Cannula's to support access for EPi-Sense catheters; and various reusable cardiac surgery instruments. It markets and sells its products through independent distributors and direct sales personnel. The company was incorporated in 2000 and is headquartered in Mason, Ohio.

Integra LifeSciences stock logo

Integra LifeSciences NASDAQ:IART

$13.26 -0.30 (-2.18%)
Closing price 03:59 PM Eastern
Extended Trading
$13.26 +0.00 (+0.04%)
As of 04:04 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.

Integra LifeSciences Holdings Corporation manufactures and sells surgical instruments, neurosurgical products, and wound care products for use in neurosurgery, neurocritical care, and otolaryngology. It operates in two segments, Codman Specialty Surgical and Tissue Technologies. The company offers neurosurgery and neuro critical care products, including tissue ablation equipment, dural repair products, cerebral spinal fluid management devices, intracranial monitoring equipment, and cranial stabilization equipment; and surgical headlamps and instrumentation, as well as after-market services. It also sells instrument patterns, and surgical and lighting products to hospitals and surgery centers, as well as dental, podiatry, and veterinary offices. In addition, the company provides regenerative technology products for the treatment of acute wounds; and surgical tissue repair products for hernia, tendon, peripheral nerve repair and protection. Further, it offers skin and wound repair, plastics and surgical reconstruction products, bone grafts, and nerve and tendon repair products. The company offers its products directly through various sales forces and other distribution channels to the hospitals, integrated health networks, group purchasing organizations, clinicians, surgery centers, and health care providers in the United States, Europe, Asia Pacific, and internationally. Integra LifeSciences Holdings Corporation was incorporated in 1989 and is headquartered in Princeton, New Jersey.

iRhythm Technologies stock logo

iRhythm Technologies NASDAQ:IRTC

$94.84 +0.60 (+0.64%)
Closing price 03:59 PM Eastern
Extended Trading
$94.79 -0.05 (-0.05%)
As of 04:04 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.

iRhythm Technologies, Inc., a digital healthcare company, engages in the design, development, and commercialization of device-based technology to provide ambulatory cardiac monitoring services to diagnose arrhythmias in the United States. It offers Zio services, an ambulatory monitoring solution, including long-term and short-term continuous monitoring and mobile cardiac telemetry monitoring services. The company also provides the Zio Monitor System, a prescription-only, remote electrocardiogram (ECG) monitoring system that consists of a patch ECG monitor that records the electric signal from the heart continuously for up to 14 days and the Zio ECG Utilization Software System, which supports the capture and analysis of ECG data recorded by the Zio Monitor patch at the end of the wear period, including specific arrhythmia events detected by the ZEUS System; the Zio XT System is the previous generation of the Zio Monitor System and is a prescription-only, remote ECG monitoring system that consists of the Zio XT patch that records the electric signal from the heart continuously for up to 14 days; and the Zio AT system, a prescription-only, remote ECG monitoring system that similarly consists of the Zio AT patch that records the electric signal from the heart continuously for up to 14 days and the ZEUS System, but which also incorporates the Zio AT wireless gateway that provides connectivity between the Zio AT patch and the ZEUS System during the patient wear period. It has a development collaboration agreement with Verily Life Sciences LLC and Verity Ireland Limited to develop various next-generation atrial fibrillation screening, detection, or monitoring products. The company was incorporated in 2006 and is headquartered in San Francisco, California.

Pulse Biosciences stock logo

Pulse Biosciences NASDAQ:PLSE

$45.46 +1.05 (+2.37%)
Closing price 03:59 PM Eastern
Extended Trading
$45.50 +0.04 (+0.09%)
As of 04:04 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.

Pulse Biosciences, Inc. operates as a novel bioelectric medicine company. The company offers CellFX System, a tunable, software-enabled, and console-based platform that delivers nano second duration pulses of electrical energy to non-thermally clear targeted cells while sparing adjacent non-cellular tissue to treat a various medical condition by using its Nano-Pulse Stimulation technology. The company was formerly known as Electroblate, Inc. and changed its name to Pulse Biosciences, Inc. in December 2015. Pulse Biosciences, Inc. was incorporated in 2014 and is headquartered in Hayward, California.